source
- Biotech investors grow uneasy as XBI stalls despite overall gainsAdam Feuerstein notes that while biotech stocks have performed well overall this year, investor sentiment has turned sour after the summer. The SPDR S&P Biotech ETF (XBI) remains up about 24% year…
- Experts call for dedicated regulatory framework for clinical AI models, UK MHRA unveils AI-focused strategyFormer FDA commissioner Scott Gottlieb, now at the American Enterprise Institute, wrote an opinion piece urging Congress to create a specific regulatory framework for artificial intelligence models…